Researchers discovered that ALPK2, a heart-specific enzyme, may protect against HFpEF by activating TPM1 in heart muscle ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of Vera Therapeutics (NasdaqGM:VERA) with a ...

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is ...

Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective lifted by analysts at Morgan Stanley from $16.00 ...

UBS raised the firm’s price target on Akero Therapeutics (AKRO ... the analyst tells investors in a research note. The firm still sees potential upside from here, and thinks the updated data ...

H.C. Wainwright lowered the firm’s price target on BioXcel Therapeutics (BTAI ... substantial,” the analyst tells investors in a research note. The firm continues to consider BXCL501 an ...

In recent trading, shares of Akero Therapeutics Inc (Symbol: AKRO) have crossed above the average analyst 12-month target price of $48.27, changing hands for $51.52/share. When a stock reaches the ...

Analysts at HC Wainwright decreased their FY2024 earnings estimates for shares of Silence Therapeutics in a report issued on ...